1. Home
  2. CLWT vs BIAF Comparison

CLWT vs BIAF Comparison

Compare CLWT & BIAF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CLWT

Euro Tech Holdings Company Limited

HOLD

Current Price

$1.45

Market Cap

11.3M

ML Signal

HOLD

Logo bioAffinity Technologies Inc.

BIAF

bioAffinity Technologies Inc.

HOLD

Current Price

$3.90

Market Cap

9.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CLWT
BIAF
Founded
1971
2014
Country
Hong Kong
United States
Employees
N/A
N/A
Industry
Professional and commerical equipment
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.3M
9.2M
IPO Year
1996
2022

Fundamental Metrics

Financial Performance
Metric
CLWT
BIAF
Price
$1.45
$3.90
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
1.4M
★ 2.9M
Earning Date
04-30-2026
11-13-2026
Dividend Yield
★ 9.39%
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $7,900,000.00
Revenue This Year
N/A
$18.58
Revenue Next Year
N/A
N/A
P/E Ratio
$17.56
★ N/A
Revenue Growth
N/A
★ 14.49
52 Week Low
$0.99
$0.37
52 Week High
$2.68
$21.52

Technical Indicators

Market Signals
Indicator
CLWT
BIAF
Relative Strength Index (RSI) 51.02 37.47
Support Level $1.46 $3.31
Resistance Level $1.74 $5.93
Average True Range (ATR) 0.15 0.81
MACD 0.03 -0.46
Stochastic Oscillator 23.85 8.78

Price Performance

Historical Comparison
CLWT
BIAF

About CLWT Euro Tech Holdings Company Limited

Euro Tech Holdings Co Ltd is mainly a distributor of a wide range of water treatment equipment, laboratory instruments, analyzers, test kits, and related supplies, and power generation equipment, including recorders and power quality analyzers. The Company acts as an exclusive or non-exclusive distributor for manufacturers of such equipment to commercial customers and governmental agencies in Hong Kong and mainland China, as well as commercial customers in Macau. It has two operating segments: Trading and manufacturing, which generate maximum revenue and act as a distributor of water treatment equipment, laboratory instruments, analyzers, test kits, related supplies, and power generation equipment; and the Engineering segment. The Company generates maximum revenue from the PRC.

About BIAF bioAffinity Technologies Inc.

bioAffinity Technologies Inc develops noninvasive diagnostic laboratory tests to detect early-stage lung cancer and other diseases of the lung using flow cytometry and automated analysis informed by machine learning, a form of artificial intelligence (AI). Its first commercial diagnostic test, CyPath Lung, identifies and analyzes cell populations using flow cytometry, including cancer and cancer-related cells, that indicate a malignancy in the lung. It is developing its flow cytometry platform to address the need to identify patients who can benefit from new and emerging therapies for asthma and chronic obstructive pulmonary disease with noninvasive precision diagnostic tests. The company is organized in two operating segments, Diagnostic Research and Development and Laboratory Services.

Share on Social Networks: